Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPAR) and its Lipid Ligands

E-ISSN： 1875-533x|21|24|2803-2821

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.24, 2014-08, pp. : 2803-2821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F Choi Brian G Fuster Valentin Badimon Juan J

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Analysis of patent applications relating to peroxisome proliferator-activated receptor (PPAR) ligands in 2004

By Miyachi Hiroyuki

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1521-1530

Informa Healthcare

Access to resources Recommend Favorite

The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 2, 2013-06 ,pp. : 175-183

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) &dgr;-Selective Ligands

Current Medicinal Chemistry, Vol. 14, Iss. 22, 2007-09 ,pp. : 2335-2343

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-01 ,pp. : 272-281

Bentham Science Publishers

Access to resources Recommend Favorite